Publications by authors named "Angelo Leo"

Claim this Profile
R
Reconfigurable Split Ring Resonators by MEMS-Driven Geometrical Tuning.
Angelo Leo, Alessandro Paolo Bramanti, Domenico Giusti, Fabio Quaglia, Giuseppe Maruccio

Sensors (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ -mutated breast cancer.
Jose Alejandro Pérez-Fidalgo, Carmen Criscitiello, Eva Carrasco, Meredith M Regan, Angelo Di Leo

Future Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Miniaturized Sensors for Detection of Ethanol in Water Based on Electrical Impedance Spectroscopy and Resonant Perturbation Method-A Comparative Study.
Angelo Leo, Anna Grazia Monteduro, Silvia Rizzato, Angelo Milone, Giuseppe Maruccio

Sensors (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.
Beverly Moy, R Bryan Rumble, Steven E Come, Nancy E Davidson, Angelo Di Leo

J Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum, Debora Fumagalli, Christos Sotiriou, Angelo Di Leo, Marco Colleoni

Cancer Discov· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Laura Pizzuti, Maddalena Barba, Marco Mazzotta, Eriseld Krasniqi, Marcello Maugeri-Saccà, Angelo Di Leo

Sci Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Femtomolar Biodetection by a Compact Core-Shell 3D Chiral Metamaterial.
Mariachiara Manoccio, Marco Esposito, Elisabetta Primiceri, Angelo Leo, Vittorianna Tasco

Nano Lett· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Serum Metabolomics Classifier Derived from Elderly Patients with Metastatic Colorectal Cancer Predicts Relapse in the Adjuvant Setting.
Samantha Di Donato, Alessia Vignoli, Chiara Biagioni, Luca Malorni, Elena Mori, Leonardo Tenori, Angelo Di Leo

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer.
Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Angelo Di Leo

NPJ Breast Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer.
Ilenia Migliaccio, Angela Leo, Francesca Galardi, Cristina Guarducci, Giulio Maria Fusco, Angelo Di Leo

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
Jose P Leone, Bernard F Cole, Meredith M Regan, Beat Thürlimann, Alan S Coates, Angelo Di Leo, Marco Colleoni

Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Francesca Galardi, Francesca De Luca, Chiara Biagioni, Ilenia Migliaccio, Giuseppe Curigliano, Angelo Di Leo

Breast Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis.
Francesco Schettini, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Angelo Di Leo

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer.
Ilenia Migliaccio, Martina Bonechi, Amelia McCartney, Cristina Guarducci, Matteo Benelli, Angelo Di Leo

Cancer Treat Rev· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies.
John F R Robertson, Angelo Di Leo, Stephen Johnston, Stephen Chia, Judith M Bliss

NPJ Breast Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE).
Giorgio Quadri, Andrea Rognoni, Enrico Cerrato, Giorgio Baralis, Giacomo Boccuzzi, Leonardo De Martino, Angelo Di Leo

Int J Cardiol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
Elena Guerini-Rocco, Kathryn P Gray, Caterina Fumagalli, Marta Rita Reforgiato, Isabella Leone, Angelo Di Leo, Marco Colleoni

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
Giulia Bon, Laura Pizzuti, Valentina Laquintana, Rossella Loria, Manuela Porru, Carlo Leonetti, Angelo Di Leo

J Exp Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Free DNA-Methylation-Based Methods and Applications in Oncology.
Francesca Galardi, Francesca De Luca, Dario Romagnoli, Chiara Biagioni, Erica Moretti, Angelo Di Leo

Biomolecules· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall Survival of CDK4/6-Inhibitor-Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis.
Francesco Schettini, Fabiola Giudici, Mario Giuliano, Massimo Cristofanilli, Grazia Arpino, Angelo Di Leo

J Natl Cancer Inst· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trial.
Zhuoxin Sun, Samuel M Niman, Olivia Pagani, Ann H Partridge, Hatem A Azim, Angelo Di Leo, Marco Colleoni

Breast· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index.
Christine Desmedt, Marco Fornili, Florian Clatot, Romano Demicheli, Davide De Bortoli, Angelo Di Leo

J Clin Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Experience With a Tapered Biodegradable Polymer-Coated Sirolimus-Eluting Stent in Patients With Long Coronary Artery Stenoses.
Alessandro Lupi, Fabrizio Ugo, Leonardo De Martino, Vincenzo Infantino, Mario Iannaccone, Angelo Di Leo

Cardiol Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
Karin Ribi, Weixiu Luo, Barbara A Walley, Harold J Burstein, Jacquie Chirgwin, Angelo Di Leo, Marco Colleoni

Breast Cancer Res Treat· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the Development of Innovative Sensor Platforms for Field Analysis.
Silvia Rizzato, Angelo Leo, Anna Grazia Monteduro, Maria Serena Chiriacò, Elisabetta Primiceri

Micromachines (Basel)· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis